Monocytes Expressing IL‐36G Play a Crucial Role in Atopic Dermatitis
Yitao Yang,
No information about this author
Lei Wang,
No information about this author
Longmei Yu
No information about this author
et al.
Journal of Cellular and Molecular Medicine,
Journal Year:
2025,
Volume and Issue:
29(7)
Published: March 30, 2025
ABSTRACT
Atopic
dermatitis
(
ad
)
is
a
chronic
inflammatory
skin
disease,
with
recent
studies
indicating
that
immune
cells,
such
as
monocytes
and
cytokines,
play
crucial
role.
By
retrieving
datasets
from
public
databases
analysing
cell
infiltration
in
lesional
using
CIBERSORT,
we
found
M2
macrophages
were
significantly
upregulated
atopic
dermatitis.
Differentially
expressed
gene
(DEG)
functional
enrichment
analysis
revealed
cytokine‐cytokine
receptor
interaction
was
the
most
enriched
pathway.
Further
of
cytokines
their
receptors,
along
correlation
infiltrating
identified
IL36G‐expressing
key
target
We
compared
cytokine‐related
targets
similar
diseases,
psoriasis
urticaria,
to
evaluate
similarities
differences
among
these
three
conditions.
The
also
highly
but
did
not
pivotal
role
urticaria.
Finally,
used
molecular
docking
predict
validate
drugs
targeting
IL36G.
Our
study
highlights
common
psoriasis,
offering
novel
insights
therapeutic
strategies
for
related
diseases.
Language: Английский
Screening for Systemic Diseases Associated with Dental Self-Care in Japanese Adolescents
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(20), P. 6087 - 6087
Published: Oct. 12, 2024
Toothbrushing
is
important
for
maintaining
oral
health
and
preventing
periodontal
disease.
However,
the
association
between
toothbrushing
systemic
diseases
remains
unclear
in
adolescence.
In
this
study,
dental
self-care
(frequency
duration
of
toothbrushing)
diseases/disorders
adolescents
was
examined.
Language: Английский
Protective Effects of Recombined Mussel Adhesive Protein against AD Skin Inflammation in Mice
Yu Wu,
No information about this author
Feng Li,
No information about this author
Yan Gong
No information about this author
et al.
Cosmetics,
Journal Year:
2024,
Volume and Issue:
11(4), P. 134 - 134
Published: Aug. 9, 2024
(1)
Background:
Atopic
dermatitis
(AD)
is
characterized
as
a
chronic
inflammatory
skin
disease
with
significant
incidence
rate.
The
pathophysiological
mechanisms
underlying
AD
remain
incompletely
understood.
However,
extensive
research
demonstrates
that
complex
interplay
among
genetic,
immune,
and
environmental
factors
contributes
to
the
disruption
of
barrier
function.
Inflammation
identified
one
pathological
in
AD.
Recombined
mussel
adhesive
protein
exhibits
anti-inflammatory
properties.
recombinant
has
been
used
less
frequently
for
AD,
so
we
explored
therapeutic
effect
potential
mechanism.
(2)
Methods:
We
established
mice
model
vivo
an
LPS-induced
inflammation
HaCaT
cells
vitro.
Through
assessment
lesion
scores,
itch
frequency,
transepidermal
water
loss,
microcirculation,
HE
staining,
Elisa
assays
IL-6,
IL-12,
IL-13,
IL-4,
IL-5,
IFN-γ,
IgE,
TNF-α,
immunohistochemical
staining
filaggrin
CK14,
Masson
Western
blot
analysis
NF-κB
p65,
P-P65,
Keap1,
Nrf2,
effects
recombined
on
symptoms,
pathology,
inflammation,
its
are
investigated.
(3)
Results:
significantly
improved
compromised
barrier,
reduced
scratching
frequency
mice,
decreased
lowered
expression
factors,
thus
ameliorating
damage.
Mechanistically,
downregulated
P-p65/p65
Keap1
while
upregulating
level
Nrf2.
(4)
Conclusions:
Overall,
our
results
demonstrate
effectiveness
attenuating
DNFB-induced
by
inhibiting
activating
Keap1/Nrf2
signaling
pathway.
Thus,
promising
candidate
treatment
Language: Английский